Publications

Year of Publication Title Faculty Association
2014 Reversal of metabolic deficits by lipoic acid in a triple transgenic mouse model of Alzheimer's disease: a 13C NMR study. Roberta Diaz Brinton, Ph.D
2014 External QX-314 inhibits evoked cranial primary afferent synaptic transmission independent of TRPV1. Tally Largent-Milnes, PhD
2014 Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand. John M. Streicher, PhD
2014 Hypoxia/reoxygenation stress signals an increase in organic anion transporting polypeptide 1a4 (Oatp1a4) at the blood-brain barrier: relevance to CNS drug delivery. Patrick T Ronaldson, PhD
2014 Differential regulation of collapsin response mediator protein 2 (CRMP2) phosphorylation by GSK3ß and CDK5 following traumatic brain injury. Rajesh Khanna
2014 Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations. George Watts, Ph.D.
2014 The functionalized amino acid (S)-Lacosamide subverts CRMP2-mediated tubulin polymerization to prevent constitutive and activity-dependent increase in neurite outgrowth. Rajesh Khanna, May Khanna, PhD
2014 Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptides. Rajesh Khanna, May Khanna, PhD
2014 Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders. Roberta Diaz Brinton, Ph.D
2014 Drug delivery to the ischemic brain. Patrick T Ronaldson, PhD
2013 Truncation of the peptide sequence in bifunctional ligands with mu and delta opioid receptor agonist and neurokinin 1 receptor antagonist activities. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Tally Largent-Milnes, PhD, Edita Navratilova, Frank Porreca, PhD, Todd Vanderah, PhD
2013 Building a better analgesic: multifunctional compounds that address injury-induced pathology to enhance analgesic efficacy while eliminating unwanted side effects. Peg Davis, Victor Hruby, Ph.D., Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2013 Potentiation of brain mitochondrial function by S-equol and R/S-equol estrogen receptor β-selective phytoSERM treatments. Roberta Diaz Brinton, Ph.D
2013 Window of opportunity for estrogen and progestin intervention in brain aging and Alzheimer's disease. Roberta Diaz Brinton, Ph.D
2013 Effect of anchoring 4-anilidopiperidines to opioid peptides. Victor Hruby, Ph.D., Josephine Lai , Ph.D., Yeon Sun Lee, Frank Porreca, PhD, Todd Vanderah, PhD
2013 Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists. Patrick W Mantyh, Tally Largent-Milnes, PhD, Frank Porreca, PhD, Todd Vanderah, PhD
2013 Development of functionally selective, small molecule agonists at kappa opioid receptors. John M. Streicher, PhD
2013 Novel fentanyl-based dual μ/δ-opioid agonists for the treatment of acute and chronic pain. Victor Hruby, Ph.D., Yeon Sun Lee, Todd Vanderah, PhD
2013 Cancer-induced bone pain: Mechanisms and models. Todd Vanderah, PhD
2013 Estrogen, astrocytes and the neuroendocrine control of metabolism. Roberta Diaz Brinton, Ph.D
2013 Lipoic acid restores age-associated impairment of brain energy metabolism through the modulation of Akt/JNK signaling and PGC1α transcriptional pathway. Roberta Diaz Brinton, Ph.D
2013 Functional selectivity of 6'-guanidinonaltrindole (6'-GNTI) at κ-opioid receptors in striatal neurons. John M. Streicher, PhD
2013 Neurosteroids as regenerative agents in the brain: therapeutic implications. Roberta Diaz Brinton, Ph.D
2013 Ovariectomy induces a shift in fuel availability and metabolism in the hippocampus of the female transgenic model of familial Alzheimer's. Roberta Diaz Brinton, Ph.D
2013 Maintenance of mitochondrial genomic integrity in the absence of manganese superoxide dismutase in mouse liver hepatocytes. George Watts, Ph.D.

Pages